Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#101 / 200 Total
IRBT - Irobot Corp - Stock Price Chart
TickerIRBT [NASD, RUT]
CompanyIrobot Corp
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap278.57MEPS (ttm)-7.76
P/E-EPS this Y52.87%
Forward P/E-EPS next Y60.94%
PEG-EPS past 5Y-
P/S0.32EPS next 5Y29.00%
P/B1.39EPS Q/Q110.16%
Dividend-Sales Q/Q-3.15%
Insider Own3.16%Inst Own74.40%
Insider Trans-16.65%Inst Trans35.45%
Short Float29.45%EarningsMay 07/a
Analyst Recom3.00Target Price12.98
Avg Volume2.13M52W Range6.48 - 51.49
May-07-24 09:00PM IRBT Stock Earnings: iRobot Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:12PM iRobot Corp (IRBT) Q1 2024 Earnings: Mixed Results Amid Restructuring Efforts (GuruFocus.com)
05:32PM iRobot appoints Gary Cohen as CEO, provides optimistic 2024 forecast (Reuters)
04:40PM IRobot: Q1 Earnings Snapshot (Associated Press Finance)
04:02PM iRobot Names Gary Cohen as New Chief Executive Officer (PR Newswire)
04:01PM iRobot Reports First-Quarter 2024 Financial Results (PR Newswire)
06:00AM Stock Market Crash Alert: 3 Must-Buy Robotics Stocks When Prices Plunge (InvestorPlace)
May-04-24 07:10PM It's Time to Rethink Holding This Beaten-Down Stock After an 80% Plummet (Motley Fool)
May-02-24 06:22AM US lawmakers investigate FTCs role in Amazon-iRobot merger failure (Retail Insight Network)
06:01AM US lawmaker investigates FTCs role in Amazon-iRobot merger failure (Retail Insight Network)
UPST - Upstart Holdings Inc - Stock Price Chart
TickerUPST [NASD, RUT]
CompanyUpstart Holdings Inc
CountryUSA
IndustryCredit Services
Market Cap1.98BEPS (ttm)-2.05
P/E-EPS this Y-29.91%
Forward P/E126.66EPS next Y124.81%
PEG-EPS past 5Y-76.37%
P/S3.69EPS next 5Y30.00%
P/B3.28EPS Q/Q52.97%
Dividend-Sales Q/Q24.16%
Insider Own14.28%Inst Own48.16%
Insider Trans-3.06%Inst Trans-14.33%
Short Float35.12%EarningsMay 07/a
Analyst Recom4.12Target Price19.46
Avg Volume5.58M52W Range12.94 - 72.58
Today 08:00AM Morgan Stanley Trims Price Target on Upstart Holdings to $12 From $13, Keeps Underweight Rating (MT Newswires) -6.58%
07:46AM Q1 2024 Upstart Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
07:31AM Reddit surges on earnings, Uber reports: Yahoo Finance (Yahoo Finance Video)
03:55AM Upstart Holdings Inc (UPST) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-07-24 10:30PM Upstart (UPST) Q1 2024 Earnings Call Transcript (Motley Fool)
09:55PM UPST Stock Earnings: Upstart Hldgs Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:35PM Upstart Holdings, Inc. (UPST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:00PM Upstart Holdings Inc (UPST) Q1 2024 Earnings: Revenue Surpasses Expectations Despite Continued ... (GuruFocus.com)
04:26PM Upstart (NASDAQ:UPST) Surprises With Q1 Sales But Quarterly Guidance Underwhelms (StockStory)
04:05PM Upstart Announces First Quarter 2024 Results (Business Wire)
BNAI - Brand Engagement Network Inc - Stock Price Chart
TickerBNAI [NASD]
CompanyBrand Engagement Network Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap60.31MEPS (ttm)-0.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.76EPS Q/Q-197.91%
Dividend-Sales Q/Q-
Insider Own54.10%Inst Own5.51%
Insider Trans0.00%Inst Trans5.83%
Short Float0.11%Earnings-
Analyst Recom-Target Price-
Avg Volume95.13K52W Range1.42 - 19.75
May-02-24 09:27AM BEN Announces Date of First Quarter 2024 Financial Results Conference Call (Business Wire) -23.22%
Apr-16-24 08:00AM BEN Partners with OSF HealthCare to Develop AI Solution for Primary Care Training & Patient Evaluation (Business Wire)
Apr-09-24 12:06PM Provana and BEN Sign Partnership to Revolutionize Business Process Management with AI Integration (Business Wire) -10.24%
Mar-14-24 06:48PM BEN Announces Closing of Business Combination, to Begin Trading on Nasdaq Under Symbol "BNAI" (Business Wire) -6.78%
MASI - Masimo Corp - Stock Price Chart
TickerMASI [NASD]
CompanyMasimo Corp
CountryUSA
IndustryMedical Devices
Market Cap6.23BEPS (ttm)1.47
P/E80.25EPS this Y-4.88%
Forward P/E29.28EPS next Y11.65%
PEG6.74EPS past 5Y-15.29%
P/S3.16EPS next 5Y11.90%
P/B4.56EPS Q/Q-10.93%
Dividend-Sales Q/Q-12.78%
Insider Own7.74%Inst Own95.58%
Insider Trans-0.97%Inst Trans3.93%
Short Float8.28%EarningsMay 07/a
Analyst Recom2.10Target Price152.22
Avg Volume520.20K52W Range75.22 - 188.14
Today 09:00AM Masimo to Present in BofA Securities Health Care Conference (Business Wire) -13.36%
03:45AM Masimo Corp (MASI) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-07-24 07:30PM Masimo (MASI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:47PM Masimo Corp (MASI) Q1 2024 Earnings: Surpasses Revenue Estimates, Aligns with EPS Projections (GuruFocus.com)
05:45PM Masimo: Q1 Earnings Snapshot (Associated Press Finance)
05:28PM Masimo Q1 Non-GAAP Net Income, Revenue Decline; Q2 Guidance Set -- Shares Rise After Hours (MT Newswires)
04:05PM Masimo Reports First Quarter 2024 Financial Results (Business Wire)
08:43AM Owlet, Inc. (NYSE:OWLT) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:11AM Masimos at-home baby monitor cleared for use without prescription (MedTech Dive)
May-06-24 08:45AM Masimo Obtains FDA Clearance for Over-The-Counter Version of Stork Baby Monitoring System (MT Newswires)
SAVA - Cassava Sciences Inc - Stock Price Chart
TickerSAVA [NASD, RUT]
CompanyCassava Sciences Inc
CountryUSA
IndustryBiotechnology
Market Cap1.00BEPS (ttm)-2.32
P/E-EPS this Y7.54%
Forward P/E-EPS next Y77.86%
PEG-EPS past 5Y-30.45%
P/S-EPS next 5Y-
P/B7.11EPS Q/Q-5.65%
Dividend-Sales Q/Q-
Insider Own7.11%Inst Own31.28%
Insider Trans0.00%Inst Trans5.13%
Short Float31.99%EarningsFeb 28/b
Analyst Recom1.00Target Price99.50
Avg Volume792.50K52W Range12.32 - 32.10
May-01-24 09:10AM Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ (GlobeNewswire)
Apr-30-24 01:16PM Stock Market Crash Warning: Don't Get Caught Holding These 3 Biotech Stocks (InvestorPlace)
Apr-15-24 09:20AM Redemption Date Announced for Warrants (GlobeNewswire) -12.04%
Mar-25-24 09:13AM Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials (GlobeNewswire)
Mar-13-24 10:45AM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava (PR Newswire)
Mar-04-24 09:15AM Cassava Sciences Announces Virtual Presentation at the AD/PD 2024 International Conference (GlobeNewswire)
Feb-28-24 09:14AM Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates (GlobeNewswire)
Feb-23-24 11:30AM CASSAVA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cassava To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Feb-08-24 10:39AM Cassava Sciences (SAVA) Stock Pops on Positive Results in Simufilam Trial (InvestorPlace)
Feb-07-24 09:08AM No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months (GlobeNewswire) +7.35%
AQST - Aquestive Therapeutics Inc - Stock Price Chart
TickerAQST [NASD]
CompanyAquestive Therapeutics Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap285.87MEPS (ttm)-0.14
P/E-EPS this Y-184.62%
Forward P/E-EPS next Y13.90%
PEG-EPS past 5Y46.61%
P/S5.65EPS next 5Y-
P/B-EPS Q/Q47.86%
Dividend-Sales Q/Q23.63%
Insider Own11.31%Inst Own26.09%
Insider Trans-0.72%Inst Trans-3.13%
Short Float4.96%EarningsMay 07/a
Analyst Recom1.12Target Price9.12
Avg Volume2.86M52W Range1.25 - 6.23
May-07-24 09:57PM AQST Stock Earnings: Aquestive Therapeutics Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00PM Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics (Zacks)
05:25PM Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:29PM Aquestive Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:19PM Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-30-24 10:01AM Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for (Zacks) -10.04%
Apr-29-24 11:19AM Aquestive Therapeutics Obtains FDA Approval for Libervant to Treat Seizure in Children (MT Newswires) -8.23%
07:00AM Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm (epinephrine) Sublingual Film (GlobeNewswire)
Apr-25-24 08:00AM Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET (GlobeNewswire)
Apr-17-24 08:00AM Coming FDA Approvals Could Send These 3 Drug Stocks Soaring (InvestorPlace)
CMPS - Compass Pathways Plc ADR - Stock Price Chart
TickerCMPS [NASD]
CompanyCompass Pathways Plc ADR
CountryUnited Kingdom
IndustryMedical Care Facilities
Market Cap580.92MEPS (ttm)-2.39
P/E-EPS this Y1.50%
Forward P/E-EPS next Y2.91%
PEG-EPS past 5Y-
P/S-EPS next 5Y3.40%
P/B2.57EPS Q/Q27.54%
Dividend-Sales Q/Q-
Insider Own8.94%Inst Own32.63%
Insider Trans-18.66%Inst Trans1.68%
Short Float5.92%EarningsMay 08/b
Analyst Recom1.00Target Price41.25
Avg Volume644.50K52W Range5.01 - 12.75
Today 06:45AM Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire) +9.82%
06:30AM Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder (GlobeNewswire)
May-03-24 04:58PM Compass Pathways to announce first quarter financial results on May 8, 2024 (GlobeNewswire)
May-02-24 06:30AM Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment (GlobeNewswire)
Apr-29-24 06:30AM Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression (GlobeNewswire)
Apr-01-24 04:01PM Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire) +16.35%
Mar-31-24 05:47PM 20 Most Depressed Countries in Asia (Insider Monkey)
Mar-28-24 08:00AM Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors (GlobeNewswire) -12.42%
Mar-19-24 08:00AM The Next Great Biotech Boom Has Arrived (PR Newswire)
Mar-10-24 10:00AM 10 Alternatives to Antidepressant Medications (Insider Monkey)
CDRE - Cadre Holdings Inc - Stock Price Chart
TickerCDRE [NYSE, RUT]
CompanyCadre Holdings Inc
CountryUSA
IndustryAerospace & Defense
Market Cap1.23BEPS (ttm)1.01
P/E29.81EPS this Y16.11%
Forward P/E22.57EPS next Y13.01%
PEG-EPS past 5Y-
P/S2.41EPS next 5Y-
P/B4.47EPS Q/Q-3.44%
Dividend1.11%Sales Q/Q23.37%
Insider Own37.24%Inst Own45.73%
Insider Trans-9.60%Inst Trans-3.69%
Short Float4.13%EarningsMay 07/a
Analyst Recom1.57Target Price42.67
Avg Volume288.53K52W Range19.13 - 39.81
Today 07:03AM Q1 2024 Cadre Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -12.07%
04:21AM Cadre Holdings Inc (CDRE) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
May-07-24 06:10PM Cadre Holdings, Inc. (CDRE) Q1 Earnings Lag Estimates (Zacks)
05:44PM Cadre Holdings Inc (CDRE) Reports Strong Q1 2024 Results, Surpassing Revenue Expectations (GuruFocus.com)
04:15PM Cadre Holdings Reports First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 10:01AM Cadre Holdings, Inc. (CDRE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-23-24 04:16PM Cadre Holdings Announces First Quarter 2024 Earnings and Conference Call Information (Business Wire)
04:15PM Cadre Holdings Declares Quarterly Dividend of $0.0875 Per Share (Business Wire)
Mar-27-24 08:30AM How Cadre Holdings (CDRE) Stock Stands Out in a Strong Industry (Zacks)
Mar-14-24 06:40PM Cadre Holdings Announces Pricing of Public Primary and Secondary Offering of Common Stock (Business Wire) -9.85%
GMED - Globus Medical Inc - Stock Price Chart
TickerGMED [NYSE]
CompanyGlobus Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap8.72BEPS (ttm)0.63
P/E102.23EPS this Y18.88%
Forward P/E19.48EPS next Y20.09%
PEG6.31EPS past 5Y-7.04%
P/S4.59EPS next 5Y16.20%
P/B2.22EPS Q/Q-110.94%
Dividend-Sales Q/Q119.26%
Insider Own17.29%Inst Own80.93%
Insider Trans-0.08%Inst Trans1.59%
Short Float6.72%EarningsMay 07/a
Analyst Recom2.29Target Price66.24
Avg Volume1.04M52W Range43.38 - 62.88
Today 07:24AM Truist Securities Raises Price Target on Globus Medical to $63 From 60, Maintains Hold Rating (MT Newswires) +25.64%
12:45AM Globus Medical (GMED) Q1 2024 Earnings Call Transcript (Motley Fool)
May-07-24 06:00PM Globus Medical (GMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:38PM Globus Medical Q1 Non-GAAP Earnings, Sales Rise; 2024 Guidance Boosted (MT Newswires)
05:30PM Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates (Zacks)
04:32PM Globus Medical: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM Globus Medical Reports First Quarter 2024 Results (GlobeNewswire)
May-06-24 09:15AM Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q1 Earnings (Zacks)
Apr-16-24 04:30PM Globus Medical Schedules First Quarter Earnings Release and Conference Call (GlobeNewswire)
Apr-15-24 09:50AM Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term (Zacks)
SEED - Origin Agritech Ltd. - Stock Price Chart
TickerSEED [NASD]
CompanyOrigin Agritech Ltd.
CountryChina
IndustryAgricultural Inputs
Market Cap25.32MEPS (ttm)1.29
P/E3.09EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.91EPS next 5Y-
P/B-EPS Q/Q4.26%
Dividend-Sales Q/Q-100.00%
Insider Own29.05%Inst Own1.70%
Insider Trans0.00%Inst Trans-12.65%
Short Float0.91%EarningsJan 08/b
Analyst Recom-Target Price-
Avg Volume322.75K52W Range1.37 - 6.50
Today 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +16.79%
Apr-02-24 07:30AM Origin Agritech Provides First Half Revenue Forecast and Updates Advancements in Hybrids and GMO Development (PR Newswire)
Mar-20-24 08:00AM Origin Agritech Announces Breakthrough in High-Yield Corn Production Through Gene Editing (PR Newswire) +7.41%
Feb-27-24 08:30AM Origin Agritech Announces Breakthrough in Corn Hybrid Development with Wild Corn Gene Integration (PR Newswire) +7.17%
Feb-21-24 07:00AM Origin Agritech Grows Revenue by 77% Year-Over-Year, Records Net Income of $8.7 Million (PR Newswire) +64.34%
Feb-20-24 07:00AM Origin Agritech Regains Compliance with Nasdaq Listing Standards (PR Newswire) -10.50%
Jan-18-24 06:00AM Origin Agritech Announces Appeal of Nasdaq Delisting Letter (PR Newswire)
Jan-08-24 07:00AM Origin Agritech Reports Fiscal Year End 2023 Results (PR Newswire)
Nov-21-23 09:00AM Origin Agritech Provides Business Updates and Answers Questions from Investors (PR Newswire) +6.47%
Nov-15-23 04:05PM Origin Agritech to Hold Business Update Conference Call on Tuesday, November 21 at 8 a.m. ET (PR Newswire) +9.95%
1⋯678910111213141516⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.